Literature DB >> 17230642

Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats.

César A J Ribeiro1, Vanessa Grando, Carlos S Dutra Filho, Clóvis M D Wannmacher, Moacir Wajner.   

Abstract

In the present study we investigated the effect of intrastriatal administration of 150 nmol quinolinic acid to young rats on critical enzyme activities of energy production and transfer, as well as on 14CO2 production from [1-14C]acetate at distinct periods after quinolinic acid injection. We observed that quinolinic acid injection significantly inhibited complexes II (50%), III (46%) and II-III (35%), as well as creatine kinase (27%), but not the activities of complexes I and IV and citrate synthase in striatum prepared 12 h after treatment. In contrast, no alterations of these enzyme activities were observed 3 or 6 h after quinolinic acid administration. 14CO2 production from [1-14C]acetate was also significantly inhibited (27%) by quinolinic acid in rat striatum prepared 12 h after injection. However, no alterations of these activities were observed in striatum homogenates incubated in the presence of 100 microm quinolinic acid . Pretreatment with the NMDA receptor antagonist MK-801 and with creatine totally prevented all inhibitory effects elicited by quinolinic acid administration. In addition, alpha-tocopherol plus ascorbate and the nitric oxide synthase inhibitor l-NAME completely abolished the inhibitions provoked by quinolinic acid on creatine kinase and complex III. Furthermore, pyruvate pretreatment totally blocked the inhibitory effects of quinolinic acid injection on complex II activity and partially prevented quinolinic acid-induced creatine kinase inhibition. These observations strongly indicate that oxidative phosphorylation, the citric acid cycle and cellular energy transfer are compromised by high concentrations of quinolinic acid in the striatum of young rats and that these inhibitory effects were probably mediated by NMDA stimulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17230642     DOI: 10.1111/j.1471-4159.2006.04199.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

1.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

2.  Asiatic acid prevents the quinolinic acid-induced oxidative stress and cognitive impairment.

Authors:  Chitra Loganathan; Palvannan Thayumanavan
Journal:  Metab Brain Dis       Date:  2017-10-31       Impact factor: 3.584

3.  A Cannabinoid Receptor-Mediated Mechanism Participates in the Neuroprotective Effects of Oleamide Against Excitotoxic Damage in Rat Brain Synaptosomes and Cortical Slices.

Authors:  Marisol Maya-López; Leonardo C Rubio-López; Ivana V Rodríguez-Alvarez; Julián Orduño-Piceno; Yuliza Flores-Valdivia; Aline Colonnello; Edgar Rangel-López; Isaac Túnez; Oscar Prospéro-García; Abel Santamaría
Journal:  Neurotox Res       Date:  2019-07-08       Impact factor: 3.911

4.  Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice.

Authors:  Alexandre Umpierrez Amaral; Bianca Seminotti; Janaína Camacho da Silva; Francine Hehn de Oliveira; Rafael Teixeira Ribeiro; Carmen Regla Vargas; Guilhian Leipnitz; Abel Santamaría; Diogo Onofre Souza; Moacir Wajner
Journal:  Neurotox Res       Date:  2017-12-12       Impact factor: 3.911

5.  Creatine prevents the inhibition of energy metabolism and lipid peroxidation in rats subjected to GAA administration.

Authors:  Janaína Kolling; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2010-09-10       Impact factor: 3.584

6.  Toxic Synergism Between Quinolinic Acid and Glutaric Acid in Neuronal Cells Is Mediated by Oxidative Stress: Insights to a New Toxic Model.

Authors:  Paula Pierozan; Ana Laura Colín-González; Helena Biasibetti; Janaina Camacho da Silva; Angela Wyse; Moacir Wajner; Abel Santamaria
Journal:  Mol Neurobiol       Date:  2017-09-21       Impact factor: 5.590

7.  Neurotoxicity of quinolinic acid to spiral ganglion cells in rats.

Authors:  Hongjun Xiao; Chen Yang; Yuanyuan He; Na Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-06-17

8.  Quinolinic Acid-Induced Huntington Disease-Like Symptoms Mitigated by Potent Free Radical Scavenger Edaravone-a Pilot Study on Neurobehavioral, Biochemical, and Histological Approach in Male Wistar Rats.

Authors:  Thangarajan Sumathi; Aishwariya Vedagiri; Surekha Ramachandran; Bhagyalakshmi Purushothaman
Journal:  J Mol Neurosci       Date:  2018-10-03       Impact factor: 3.444

9.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention.

Authors:  Robert D Oades; Aye-Mu Myint; Maria R Dauvermann; Benno G Schimmelmann; Markus J Schwarz
Journal:  Behav Brain Funct       Date:  2010-06-09       Impact factor: 3.759

10.  Oxidative Stress, Disrupted Energy Metabolism, and Altered Signaling Pathways in Glutaryl-CoA Dehydrogenase Knockout Mice: Potential Implications of Quinolinic Acid Toxicity in the Neuropathology of Glutaric Acidemia Type I.

Authors:  Bianca Seminotti; Alexandre Umpierrez Amaral; Rafael Teixeira Ribeiro; Marília Danyelle Nunes Rodrigues; Ana Laura Colín-González; Guilhian Leipnitz; Abel Santamaría; Moacir Wajner
Journal:  Mol Neurobiol       Date:  2015-11-25       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.